HUMA
Humacyte, Inc. · Healthcare
Director Brady W Dougan sold $4.5M of Humacyte, Inc.
Sold$4,520,024
$7.17Price
630,148Shares
−9%Stake
What HUMA did after the filing
- The stock from Thu, Jun 13 close, $7.20
- +9.0%
- S&P 500, same days
- +0.7%
Measured over 30 trading days, to the Jul 29 close.
Traded Tue, Jun 11. Filed Thu, Jun 13, 12:47 PM ET, during the session. Returns use the Jun 13 close and the Jul 29 close. Not investment advice.